160 related articles for article (PubMed ID: 24375455)
1. MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressors.
Gits CM; van Kuijk PF; Jonkers MB; Boersma AW; Smid M; van Ijcken WF; Coindre JM; Chibon F; Verhoef C; Mathijssen RH; den Bakker MA; Verweij J; Sleijfer S; Wiemer EA
Int J Cancer; 2014 Jul; 135(2):348-61. PubMed ID: 24375455
[TBL] [Abstract][Full Text] [Related]
2. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.
Yu PY; Balkhi MY; Ladner KJ; Alder H; Yu L; Mo X; Kraybill WG; Guttridge DC; Iwenofu OH
Lab Invest; 2016 Apr; 96(4):481-91. PubMed ID: 26878133
[TBL] [Abstract][Full Text] [Related]
3. Liposarcoma miRNA signatures identified from genome-wide miRNA expression profiling.
Zhou Y; Zhang Y; Huang Y; Tan R; Liu T; Zhuang R; Zhu M; Han W; Hou Y; Liu J; Zhang L; Jiang Y; Tong H; Shao Y; Zhu J; Lu W
Future Oncol; 2014 Jun; 10(8):1373-86. PubMed ID: 25052748
[TBL] [Abstract][Full Text] [Related]
4. Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.
Ugras S; Brill E; Jacobsen A; Hafner M; Socci ND; Decarolis PL; Khanin R; O'Connor R; Mihailovic A; Taylor BS; Sheridan R; Gimble JM; Viale A; Crago A; Antonescu CR; Sander C; Tuschl T; Singer S
Cancer Res; 2011 Sep; 71(17):5659-69. PubMed ID: 21693658
[TBL] [Abstract][Full Text] [Related]
5. Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosis.
Kapodistrias N; Mavridis K; Batistatou A; Gogou P; Karavasilis V; Sainis I; Briasoulis E; Scorilas A
Oncotarget; 2017 Jan; 8(4):6896-6913. PubMed ID: 28036291
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA profiling of primary high-grade soft tissue sarcomas.
Renner M; Czwan E; Hartmann W; Penzel R; Brors B; Eils R; Wardelmann E; Büttner R; Lichter P; Schirmacher P; Mechtersheimer G
Genes Chromosomes Cancer; 2012 Nov; 51(11):982-96. PubMed ID: 22811003
[TBL] [Abstract][Full Text] [Related]
8. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
9. miR-193b-Regulated Signaling Networks Serve as Tumor Suppressors in Liposarcoma and Promote Adipogenesis in Adipose-Derived Stem Cells.
Mazzu YZ; Hu Y; Soni RK; Mojica KM; Qin LX; Agius P; Waxman ZM; Mihailovic A; Socci ND; Hendrickson RC; Tuschl T; Singer S
Cancer Res; 2017 Nov; 77(21):5728-5740. PubMed ID: 28882999
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
[TBL] [Abstract][Full Text] [Related]
11. Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.
Guled M; Pazzaglia L; Borze I; Mosakhani N; Novello C; Benassi MS; Knuutila S
Genes Chromosomes Cancer; 2014 Aug; 53(8):693-702. PubMed ID: 24771630
[TBL] [Abstract][Full Text] [Related]
12. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
13. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
14. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma.
Fritz B; Schubert F; Wrobel G; Schwaenen C; Wessendorf S; Nessling M; Korz C; Rieker RJ; Montgomery K; Kucherlapati R; Mechtersheimer G; Eils R; Joos S; Lichter P
Cancer Res; 2002 Jun; 62(11):2993-8. PubMed ID: 12036902
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of well-differentiated/de-differentiated liposarcomas by high-resolution oligonucleotide array-based comparative genomic hybridization.
Tap WD; Eilber FC; Ginther C; Dry SM; Reese N; Barzan-Smith K; Chen HW; Wu H; Eilber FR; Slamon DJ; Anderson L
Genes Chromosomes Cancer; 2011 Feb; 50(2):95-112. PubMed ID: 21117066
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of microRNAs in gastrointestinal stromal tumors revealed by high throughput quantitative RT-PCR microarray.
Tong HX; Zhou YH; Hou YY; Zhang Y; Huang Y; Xie B; Wang JY; Jiang Q; He JY; Shao YB; Han WM; Tan RY; Zhu J; Lu WQ
World J Gastroenterol; 2015 May; 21(19):5843-55. PubMed ID: 26019448
[TBL] [Abstract][Full Text] [Related]
17. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
[TBL] [Abstract][Full Text] [Related]
18. Deregulation of dicer and mir-155 expression in liposarcoma.
Vincenzi B; Iuliani M; Zoccoli A; Pantano F; Fioramonti M; De Lisi D; Frezza AM; Rabitti C; Perrone G; Onetti Muda A; Russo A; Giordano A; Santini D; Dei Tos AP; Tonini G
Oncotarget; 2015 Apr; 6(12):10586-91. PubMed ID: 25888631
[TBL] [Abstract][Full Text] [Related]
19. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
